Skip to main content
SPTX $17.93 -2.10%
SPTX logo
SPTX · Seaport Therapeutics, Inc.
Track SPTX — free
$17.93 -0.39 (-2.10%)
Market Cap
$980.14M
Shares
53.53M
Volume · Nov 19 64.53K Avg daily vol (3M) 252.84K
All webcasts

Earnings call · FY2026 Q3

Seaport Therapeutics, Inc. (SPTX) Q3 2026 Earnings Call

Concluded Nov 2, 2026
Nov 2, 2026
Period
FY2026 Q3
Runtime
—
Sources
2 artifacts
Diluted EPS -$0.49
Net income -$26.39M
Open full screen 8-K 10-Q

Executive readout · one minute

What the filings say

8-K earnings release · filed Nov 2, 2026
Seaport Therapeutics reported a third-quarter 2026 net loss of $26.4 million, versus $22.5 million a year earlier. Cash, cash equivalents and investments totaled $403.8 million at September 30, 2026, expected to fund operations into 2029.
10-Q report · filed Nov 2, 2026
Seaport Therapeutics reported a $114.4 million nine-month net loss and $403.8 million in cash, cash equivalents and investments, which management believes will fund operations into 2029 after its IPO.

The audio replay and transcript follow the call.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document